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A B S T R A C T
Purpose: The problems of mood disorders are critical in people with epilepsy. Therefore, there is a need to
validate a useful tool for the population. The Hospital Anxiety and Depression Scale (HADS) has been used
on the population, and showed that it is a satisfactory screening tool. However, more evidence on its
construct validity is needed.
Method: A total of 1041 people with epilepsy were recruited in this study, and each completed the HADS.
Conﬁrmatory factor analysis (CFA) and Rasch analysis were used to understand the construct validity of
the HADS. In addition, internal consistency was tested using Cronbachs’ a, person separation reliability,
and item separation reliability. Ordering of the response descriptors and the differential item functioning
(DIF) were examined using the Rasch models.
Results: The HADS showed that 55.3% of our participants had anxiety; 56.0% had depression based on its
cutoffs. CFA and Rasch analyses both showed the satisfactory construct validity of the HADS; the internal
consistency was also acceptable (a = 0.82 in anxiety and 0.79 in depression; person separation
reliability = 0.82 in anxiety and 0.73 in depression; item separation reliability = 0.98 in anxiety and 0.91 in
depression). The difﬁculties of the four-point Likert scale used in the HADS were monotonically
increased, which indicates no disordering response categories. No DIF items across male and female
patients and across types of epilepsy were displayed in the HADS.
Conclusions: The HADS has promising psychometric properties on construct validity in people with
epilepsy. Moreover, the additive item score is supported for calculating the cutoff.
© 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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People with epilepsy are in high risk of having mood disorders:
up to 55% of people with refractory epilepsy may have depression
[1,2]. A study even found that the prevalence of people with
refractory temporal lobe epilepsy having psychiatric disorders up
to 70% [3]. Due to the high prevalence of mood disorders, people
with epilepsy showed a higher suicide rate (12%) than the general
population (1%) [4]. As a result, measuring the mood disorder in
terms of anxiety and depression is a critical topic for clinicians [5].Abbreviations: HADS, Hospital Anxiety and Depression Scale; CFI, conﬁrmatory
factor analysis; RMSEA, root mean square error of approximation; SRMR,
standardized root mean square residual; SEM, structural equation model; TLI,
Tucker–Lewis index; inﬁt, information-weighted ﬁt statistic; MnSq, mean square;
outﬁt, outlier-sensitive ﬁt statistic.
* Corresponding author. Fax: +98 28 33239259.
E-mail addresses: Pakpour_Amir@yahoo.com, apakpour@qums.ac.ir,
Amir.Pakpour@ju.se (A.H. Pakpour).
http://dx.doi.org/10.1016/j.seizure.2016.11.019
1059-1311/© 2016 British Epilepsy Association. Published by Elsevier Ltd. All rights resIn order to tackle the mood disorder issues in people with
epilepsy, some researchers claim the importance of validating
useful screening instruments [2,6]. They ﬁnally suggested that
Neurological Disorders Depression Inventory for Epilepsy (NDDI-
E) [7,8], Hospital Anxiety and Depression Scale (HADS) [9], and
Beck Depression Inventory (BDI) [10] are useful to screen
depression for people with epilepsy. Some studies also showed
that HADS is a promising tool to assess the depression for people
with epilepsy [11–13], and the beneﬁt of using HADS is that the
instrument has no items relating to somatic symptoms, a
confounder to the diagnosis [2].
However, the knowledge of using HADS on people with epilepsy
seems to be insufﬁcient in its psychometric evaluation. Speciﬁcally,
all studies only focus on the ability of screening depression [2,8,11–
13]. Therefore, we do not have the full picture of the psychometric
properties for HADS on people with epilepsy, such as the construct
validity and internal consistency. Also, we do not know whether
the HADS has the ability to assess anxiety for people with epilepsy.
For example, we do not know whether the descriptors of theerved.
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interpret the HADS similarly.
In addition to the traditional methods, Rasch analysis is an
alternative to test psychometric properties of an instrument. The
simplest Rasch uses a logistic equation (Pi = [exp(u  bi)]/[1 + exp
(u  bi)], where Pi denotes the probability of correct answer on
item i, and bi denotes the item difﬁculty) [14] to estimate the
underlying ability of a respondent, and the difﬁculty of each item.
Other extensions of the Rasch analysis have been developed for
different response scales (e.g., the ordinal and interval scales)
[15,16]. Although Rasch analysis is not a statistical technique that
the clinicians are familiar with [17], the beneﬁts of using it include
(a) separately estimating person ability and item difﬁculty; (b)
assessing whether different groups interpret the same item in
different ways; (c) testing the item validity and the unidimension-
ality of the entire instrument; (d) investigating the appropriate-
ness of the response descriptors [18,19]. Therefore, some articles
[20,21] suggest applying Rasch models along with traditional
psychometric methods to examine the reliability and validity of an
outcome instrument.
The aim of this study was to examine the construct validity and
internal consistency of the HADS using advanced psychometric
methods. Conﬁrmatory factor analysis (CFA) and Rasch models
were used to investigate the construct validity. Additional tests
related to Rasch models were adopted to understand the
appropriateness of the response descriptors and to examine the
interpretation on HADS between male and female patients.
2. Methods
2.1. Participants and procedure
The study participants were epileptic patients who were
referred to six neurologic centers in Tehran and Qazvin from July
2015 to through October 2015. The study measure was
administrated by a trained nurse. Eligibility criteria included
conﬁrmed diagnosis of epilepsy by neurologist and being able to
read and write Persian. Patients were excluded from the study if
they had intellectual disability, cognitive impartment and did not
agree to complete informed consent. The study protocol was
approved by the research ethics committee of the Qazvin
University of Medical Sciences. All participants gave their written
informed consent.
2.2. Hospital Anxiety and Depression Scale (HADS)
Zigmond and Snaith [9] developed the 14-item HADS to
measure the anxiety (7 items) and depression (7 items) of patients
with both somatic and mental problems. The response descriptors
of all items are Yes, deﬁnitely (score 3); Yes, sometimes (score 2); No,
not much (score 1); No, not at all (score 0); except for items 7 and 10,
which are scored reversely. A higher score represents higher levels
of anxiety and depression: a domain score of 11 or greater indicates
anxiety or depression; 8–10 indicates borderline case; 7 or lower
indicates no signs of anxiety or depression. The two-factor
framework of the HADS has been supported in cancer patients
[22], HIV patients [23], and a general population of Norway [24].
The internal consistency of was good in both domains (0.80 in
anxiety and 0.76 in depression) [24]. Moreover, the Iranian version
of HADS has linguistic validity, acceptable internal consistency
(0.78 in anxiety and 0.86 in depression), and satisfactory known-
group validity (signiﬁcant differences were found in different
stages of cancer patients) [25].2.3. Data analysis
Demographics of the participants were described using mean,
SD, and frequency. In addition, we used three CFAs to examine the
construct validity of the HADS: two one-factor models and one
two-correlated-factor model. The one-factor models respectively
had the latent construct of anxiety and depression, while the two-
correlated-factor model simultaneously adopted the two con-
structs (anxiety and depression). Because the HADS is rated on a
four-point Likert scale, we used diagonally weighted least squares
(DWLS) estimator rather than using maximum likelihood (ML)
estimator in the CFA. Moreover, we used the following cutoffs in
different ﬁt indices to determine an acceptable model: normed x2
(i.e., x2 value divided by the degrees of freedom) <3, comparative
ﬁt index (CFI) and Tucker–Lewis index (TLI) >0.95, root mean
square of error approximation (RMSEA) and standardized root
mean square residual (SRMR) <0.08 [26–29]. Rasch analyses were
also used to test the construct validity in terms of unidimension-
ality of the HADS. Speciﬁcally, two rating scale models (RSM) were
adopted: one for anxiety and another for depression. Two statistics,
information-weighted ﬁt statistic (inﬁt) mean square (MnSq) and
outlier-sensitive ﬁt statistic (outﬁt) MnSq, were used to test the
item ﬁt. An item with inﬁt or outﬁt MnSq out of the 0.5–1.5 range is
misﬁt [21]. In addition to the construct validity, internal
consistency of the HADS was also examined using classical test
theory (i.e., Cronbach’s a) and Rasch models (i.e., separation
reliability), and acceptable value for internal consistency is >0.7
[19].
Based on Rasch analysis, each item has a difﬁculty value that
suggests how hard/easy for the respondents to fulﬁll the item
description. Also, each response descriptor has different difﬁcul-
ties, and we anticipated the difﬁculty increased by the rating score
(i.e., score 3 is harder than score 2, score 2 is harder than score 1 to
fulﬁll each item description, and so on). Therefore, we used the
average and step measures of the descriptors to determine
whether disordering threshold exists in the HADS. In addition to
the monotonically increased difﬁculties, inﬁt and outﬁt MnSq
within 0.5 and 1.5 suggest no disordering [30]. Finally, we tested
the differential item functioning (DIF) across gender. We used both
statistical test and DIF contrast (the difﬁculty for male minus the
difﬁculty for female) to understand whether male patients with
epilepsy interpret any HADS items differently from the female
patients, and a DIF contrast >0.5 indicates a substantial DIF [31].
That is, male and female patients interpret the same item in
different ways. We also tested the DIF across two types of epilepsy
(generalized vs. localization related).
Demographics were analyzed using SPSS 17.0 (SPSS Inc.,
Chicago, IL, USA); CFAs using lavaan package in the R software
[32]; Rasch models using WINSTEPS [33].
3. Results
Table 1 also shows the demographic information and the
clinical characteristics of the participants; speciﬁcally, the mean
(SD) age of the participants was 39.1 (7.0) years with a mean
educational year of 5.1 (1.2). Although all the patients ﬁlled out the
HADS, some reported missing values: 42 did not fully answer the
anxiety domain of the HADS; 47 did not fully answer the
depression domain of the HADS. Because the number of patients
with missing values was little (<5%), their HADS data were
excluded in both CFA and Rasch models. Of those who (n = 999) had
fully answered the anxiety domain of the HADS (response
rate = 96.0%), 33.8% (n = 352) had anxiety and 21.5% (n = 224) were
borderline case based on the suggested cutoff. Of those who
(n = 994) had fully answered the depression domain of the HADS
Table 1
Participant characteristics.
Mean or n SD or %
Age (year) 39.1 7.0
Seizure frequency in the past year 10.8 8.19
Disease duration (years) 23.94 13.89
Gender
Male 451 43.3%
Female 590 56.7%
Educational year 5.1 1.2
Currently smoking (yes) 321 30.8%
Currently drinking (yes) 307 29.5%
Marital status
Single 235 22.6%
Married 778 74.7%
Widowed 28 2.7%
Economic status
Very good 12 1.2%
Good 152 14.6%
Neutral 643 61.8%
Bad 181 17.4%
Very bad 53 5.1%
Epilepsy type
Generalized 380 36.50%
Localization related 593 56.96%
Not deﬁned 68 6.53%
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(n = 259) were at the borderline based on the suggested cutoff.
CFA results revealed that all proposed models (i.e., two one-factor
models and a two-correlated-factor model) were all satisfactory orTable 2
Conﬁrmatory factor analysis (CFA) results.
Fit indices Models
One factor: Anxiety 
x2 (df) 37.675 (14) 
Normed x2 2.69 
CFI 0.994 
TLI 0.991 
RMSEA (95%CI) 0.041 (0.026, 0.057) 
SRMR 0.040 
Normed x2 = x2 divided by df.
CFI = comparative ﬁt index; TLI = Tucker–Lewis index; RMSEA = root mean squar
CI = conﬁdence interval.
Table 3
Standardized factor loadings in conﬁrmatory factor analysis (CFA) and Rasch difﬁcultie
Domain 
Items description 
Anxiety
1. I feel tense or wound up 
3. I get a sort of frightened feeling as if something awful is about to happen 
5. Worrying thoughts go through my mind 
7. I can sit as ease and feel relaxed 
9. I get a sort of frightened feeling like ‘butterﬂies’ in the stomach 
11. I feel restless as if I have to be on the move 
13. I get sudden feelings of panic 
Depression
2. I still enjoy the things I used to enjoy 
4. I can laugh and see the funny side of things 
6. I feel cheerful 
8. I feel as if I am slowed down 
10. I have lost interest in my appearance 
12. I look forward with enjoyment to things 
14. I can enjoy a good book or TV program 
Inﬁt = information-weighted ﬁt statistic; Outﬁt = outlier-sensitive ﬁt statistics; MnSq = m
a Loadings are derived from two-correlated-factor model.close to acceptable in the data-model ﬁt indices, including the
normed x2 (0.83–3.57), CFI (0.985–1.000), TLI (0.982–1.000),
RMSEA (0.000–0.052), and SRMR (0.021–0.059) (Table 2); factor
loadings were all signiﬁcant and >0.3 in the two-correlated-factor
model (Table 3). In addition, the internal consistency was good in
both domains whether using classical test theory (a = 0.82 in
anxiety and 0.79 in depression) or separation reliability in Rasch
models (person separation reliability = 0.82 in anxiety and 0.73 in
depression; item separation reliability = 0.98 in anxiety and 0.91 in
depression). Moreover, all items, which difﬁculties were from 0.77
to 0.55 in anxietyand 0.17 to 0.26 in depression, had ﬁt well in their
embedded latent constructs as the inﬁt and outﬁt MnSq all fell
between 0.5 and 1.5 (Table 3).
The difﬁculties of the responses (i.e., the four-point Likert scale)
were monotonically increased in both average and step measures
for both anxiety and depression domains. In addition, the inﬁt and
outﬁt MnSq were all fell between 0.5 and 1.5 (Table 4), and
suggested no threshold disordering. As for DIF testing, our results
showed that there were no DIF items across male and female
patients; and across two types of epilepsy as all DIF contrasts were
less than 0.5 and nonsigniﬁcant (Table 5).
4. Discussion
Our results showed that HADS has promising psychometric
properties in terms of the construct validity and internal
consistency in people with epilepsy. Although many studies have
found that HADS has satisfactory construct validity usingOne factor: Depression Two-correlated-factor
11.661 (14) 270.981 (76)
0.83 3.57
1.000 0.985
1.000 0.982
0.000 (0.000, 0.026) 0.052 (0.045, 0.058)
0.021 0.059
e of error approximation; SRMR = standardized root mean square residual;
s and ﬁt statistics for each item.
CFA Rasch
Loadingsa Difﬁculties Inﬁt MnSq Outﬁt MnSq
0.534 0.15 1.31 1.32
0.781 0.52 1.03 1.03
0.626 0.77 1.11 1.13
0.767 0.15 0.79 0.80
0.586 0.21 0.97 0.95
0.786 0.21 0.75 0.75
0.596 0.55 1.03 1.00
0.594 0.17 0.72 0.77
0.710 0.26 0.66 0.68
0.793 0.10 0.71 0.72
0.731 0.10 0.99 0.97
0.498 0.06 1.34 1.33
0.380 0.24 1.14 1.13
0.494 0.06 1.44 1.43
ean square.
Table 4
Response disordering tests.
Average measure Step measure Inﬁt MnSq Outﬁt MnSq
Anxiety
0 3.66 – 1.15 1.11
1 1.10 2.53 0.90 0.91
2 1.28 0.39 0.85 0.83
3 3.35 2.13 1.11 1.15
Depression
0 2.85 – 1.08 1.07
1 0.83 1.64 0.90 0.92
2 0.89 0.17 0.94 0.94
3 2.73 1.47 1.03 1.06
0: No, not at all; 1: No, not much; 2: Yes, sometimes; 3: Yes, deﬁnitely.
Scores of items 7 and 10 were reversely coded.
Inﬁt = information-weighted ﬁt statistic; Outﬁt = outlier-sensitive ﬁt statistics;
MnSq = mean square.
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not people with epilepsy, and our study seems to be the ﬁrst on the
population. Also, the importance of using HADS on people with
epilepsy has been noticed, and several studies [2,8,11–13] test the
psychometric properties of HADS on the population. However, to
the best of our knowledge, no studies have used CFA or Rasch
models. Also, we elaborated the issues of response descriptors and
DIF for HADS in people with epilepsy, and found that HADS has
adequate response descriptors and no DIF items. The aforemen-
tioned issues have never been tackled for HADS in population with
epilepsy.
Previous studies examining psychometric properties of HADS
on people with epilepsy emphasize the cutoffs and its predictive
ability for screening depression [2,11–13]. The cutoff information is
important for clinicians to make clinical decision; however, we feel
that ensuring all the items on HADS embedded in their belonging
construct is the major assumption to test the cutoffs. If some items
do not have acceptable construct validity, the cutoffs for screening
may be biased; that is, those items without acceptable construct
validity should not be included for calculation cutoffs. Therefore,
our results support previous studies using all item scores in
depression domain of HADS to decide the cutoffs [2,11–13].
Another important assumption for using all HADS item scores
to determine the cutoffs is the ordered response descriptors. Our
results suggest that all response descriptors were in order, and
support the use of cutoffs explored by previous studies [2,11–13].
In practical use, summing up the item scores is the most feasibleTable 5
Differential item functioning (DIF) across gender and across types of epilepsy.
Item # Difﬁ
Male
Anxiety
1. I feel tense or wound up 0.1
3. I get a sort of frightened feeling as if something awful is about to happen 0.47 
5. Worrying thoughts go through my mind 0.7
7. I can sit as ease and feel relaxed 0.1
9. I get a sort of frightened feeling like ‘butterﬂies’ in the stomach 0.2
11. I feel restless as if I have to be on the move 0.29
13. I get sudden feelings of panic 0.55
Depression
2. I still enjoy the things I used to enjoy 0.1
4. I can laugh and see the funny side of things 0.22
6. I feel cheerful 0.1
8. I feel as if I am slowed down 0.01 
10. I have lost interest in my appearance 0.03
12. I look forward with enjoyment to things 0.16 
14. I can enjoy a good book or TV program 0.1
DIF contrasts = Difﬁculty in male–difﬁculty in female, and all DIF contrasts were nonsigand efﬁcient method to evaluate the performance of an individual.
However, an assumption should be fulﬁlled before summing up the
item scores; that is, the item score is coherent to its descriptor. For
example, if a patient interprets the severity of score 2 descriptor
being less than or equal to that of score 3, then, the summated
score would be biased. In other words, we need to ensure that the
severity of score 3 being greater than that of score 2; score 2 greater
than score 1; score 1 greater than score 0. Then, the summated
cutoffs could be meaningful. Apparently, no studies have noticed
the assumption for the HADS, and we seemed to be the ﬁrst to
examine the order of response descriptors. Nevertheless, our
results revealed the appropriateness of summing up the score, and
the assumption is fulﬁlled for the HADS.
In addition to the depression, we extended the use of HADS to
anxiety for people with epilepsy. Although only a few studies
discussed the anxiety for people with epilepsy [34–37], the topic
should not be ignored because anxiety also impacts an individual’s
quality of life [34]. Our results suggest that all items of HADS on
anxiety domain had satisfactory construct validity, and future
studies may want to further use the items in anxiety domain to
develop the cutoffs for screening.
In addition, the interpretations of item descriptions in HADS
between genders should be investigated. If females and males
interpret an item description in different ways, it means that the
item is unfair to measure the score of the latent construct [20,38].
Therefore, a good item should display no DIF across genders, and
our results showed that all HADS items had no DIF across male and
female patients. Similarly, a study [39] on a general population of
North East Scotland found almost no DIF items in HADS across
gender, except for item 11 (I feel restless as if I have to be on the
move). Nevertheless, we agree with Cameron et al. [39] that using
HADS across gender is appropriate. We further demonstrated that
using HADS across types of epilepsy (generalized and localization
related epilepsies) is appropriate.
The study has some limitations. First, all patients were recruited
only from two cities. It is possible that more severe patients had
been referred to other cities, and the generalizability of our results
is somewhat limited. Second, this study did not assess the
associations between anxiety, depression, and socio-clinical
variables. That is, in this current study, we did not have a gold
standard to help us determine the concepts of the HADS are on
anxiety and depression. Although previous evidence has showed
that the HADS is well correlated with other gold standards (e.g.,
DSM-IV), we did not have such information in the current study.culty in gender DIF
contrast
Difﬁculty in epilepsy type DIF
contrast
 Female Generalized Localization related
2 0.17 0.05 0.15 0.15 0.00
0.56 0.09 0.59 0.52 0.07
3 0.80 0.07 0.77 0.79 0.02
9 0.12 0.07 0.15 0.15 0.00
9 0.15 0.15 0.24 0.19 0.05
 0.14 0.15 0.21 0.24 0.03
 0.55 0.00 0.55 0.55 0.00
7 0.17 0.00 0.05 0.22 0.17
 0.28 0.06 0.29 0.22 0.07
0 0.10 0.00 0.07 0.10 0.03
0.17 0.18 0.10 0.10 0.00
 0.13 0.16 0.13 0.01 0.12
0.29 0.13 0.17 0.27 0.10
3 0.02 0.11 0.11 0.06 0.05
niﬁcant.
46 C.-Y. Lin, A.H. Pakpour / Seizure 45 (2017) 42–46Therefore, we were unable to demonstrate the relationship
between HADS and other gold standards. Third, although our
results demonstrate the DIF across gender and two types of
epilepsy (generalized vs. localization related); clinicians and
researchers should note that we did not examine DIF across other
signiﬁcantly clinical or demographic characteristics (e.g., patients
with well controlled or refractory epilepsies; patients with mesial
temporal lobe epilepsy related to hippocampus sclerosis, patients
with absence or myoclonic juvenile epilepsy). The HADS items are
possibly to be interpreted differently across these important
characteristics; however, we did not have such information to test
the DIF. Future studies are warranted to elaborate the DIF issue
across these signiﬁcant demographics for people with epilepsy.
In conclusion, HADS has sound psychometric properties in
people with epilepsy. Summing up the item scores is appropriate
as the response descriptors were scored in order and all items were
valid. Because all items were valid in both CFA and Rasch models,
we suggest that using all the items to measure anxiety and
depression for people with epilepsy is suitable. However, future
studies may want to explore more in the anxiety domain of HADS
for people with epilepsy because most studies only focus on the
depression domain.
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